Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GeneFerm Biotechnology (Jin Ying) is a leading biotechnology company based in Taiwan, specializing in microbial fermentation and the development of functional ingredients for the healthcare and nutraceutical industries. The company operates as a specialized CDMO, providing high-quality fermentation, extraction, and purification services for a wide range of products including probiotics, enzymes, and fungal extracts like Antrodia cinnamomea. GeneFerm leverages advanced biotechnology to produce proprietary functional materials that target immune support, liver health, and metabolic wellness. With a strong focus on R&D and international quality standards, the company serves global markets by providing both raw materials and finished health products. GeneFerm is publicly traded on the Taiwan Stock Exchange and is recognized for its expertise in large-scale microbial production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jin Ying.